Charles Schwab’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $89M | Buy |
|
|||||
|
2025
Q2 | $59.8M | Sell |
|
|||||
|
2025
Q1 | $118M | Sell |
|
|||||
|
2024
Q4 | $53M | Buy |
|
|||||
|
2024
Q3 | $47.5M | Buy |
|
|||||
|
2024
Q2 | $31.6M | Buy |
|
|||||
|
2024
Q1 | $23.5M | Buy |
|
|||||
|
2023
Q4 | $29.2M | Buy |
|
|||||
|
2023
Q3 | $23.5M | Buy |
|
|||||
|
2023
Q2 | $18.8M | Sell |
|
|||||
|
2023
Q1 | $19.3M | Sell |
|
|||||
|
2022
Q4 | $18.1M | Buy |
|
|||||
|
2022
Q3 | $21.1M | Buy |
|
|||||
|
2022
Q2 | $19.4M | Buy |
|
|||||
|
2022
Q1 | $17.7M | Buy |
|
|||||
|
2021
Q4 | $13.5M | Sell |
|
|||||
|
2021
Q3 | $15.1M | Sell |
|
|||||
|
2021
Q2 | $16.8M | Sell |
|
|||||
|
2021
Q1 | $18.8M | Buy |
|
|||||
|
2020
Q4 | $20M | Buy |
|
|||||
|
2020
Q3 | $13.1M | Sell |
|
|||||
|
2020
Q2 | $12.9M | Buy |
|
|||||
|
2020
Q1 | $8.22M | Buy |
|
|||||
|
2019
Q4 | $8.31M | Buy |
|
|||||
|
2019
Q3 | $8.49M | Buy |
|
|||||
|
2019
Q2 | $6.61M | Buy |
|
|||||
|
2019
Q1 | $6.83M | Buy |
|
|||||
|
2018
Q4 | $7.51M | Buy |
|
|||||
|
2018
Q3 | $7.88M | Buy |
|
|||||
|
2018
Q2 | $7.89M | Buy |
|
|||||
|
2018
Q1 | $8.07M | Buy |
|
|||||
|
2017
Q4 | $8.69M | Buy |
|
|||||
|
2017
Q3 | $7.99M | Buy |
|
|||||
|
2017
Q2 | $4.37M | Buy |
|
|||||
|
2017
Q1 | $3.73M | Buy |
|
|||||
|
2016
Q4 | $2.33M | Buy |
|
|||||
|
2016
Q3 | $1.82M | Buy |
|
|||||
|
2016
Q2 | $639K | Buy |
|
|||||
|
2016
Q1 | $405K | Hold |
|
|||||
|
2015
Q4 | $431K | Hold |
|
|||||
|
2015
Q3 | $326K | Hold |
|
|||||
|
2015
Q2 | $520K | Buy |
|
|||||
|
2015
Q1 | $384K | Hold |
|
|||||
|
2014
Q4 | $206K | Hold |
|
|||||
|
2014
Q3 | $184K | Hold |
|
|||||
|
2014
Q2 | $192K | Hold |
|
|||||
|
2014
Q1 | $299K | Hold |
|
|||||
|
2013
Q4 | $221K | Hold |
|
|||||
|
2013
Q3 | $111K | Hold |
|
|||||
|
2013
Q2 | $122K | Buy |
|